Summary
July 2024–June 2025
THE COLLEGE
THE
ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS (RANZCR)
OUR PURPOSE
To advance excellence in diagnostic, interventional, and cancer care medicine, to optimise health outcomes for our patients and society.
We deliver against our purpose through:
Members We meet (or exceed) member expectations, supporting them into, through, and beyond their career journey.
Our people We employ, develop, and encourage our people to align with our “member-centric” culture, to deliver outstanding solutions for our members.
Education We set the standard for world-class trainee and member training, education, and lifelong development, to drive clinical excellence.
Policy and advocacy We are the leading voice of our sector and through research and standards, shape the policy agenda with government, regulators, members and external stakeholders.
Organisational responsibility Under a strong governance structure, we operate within legal and regulator frameworks, in a socially responsible and financially sustainable manner.
BOARD OF DIRECTORS
OUR VALUES
RESPECT
We treat each other, our members, and our stakeholders with the same dignity and respect that we would expect for ourselves. We hold each other to this standard.
ACCOUNTABILITY
We take ownership and responsibility for our actions, behaviour, performance, and commitments.
INNOVATION
We encourage our people to imagine ‘what could be’; to be curious and brave. We recognise and celebrate new initiatives and advances in how we deliver our purpose.
INCLUSIVITY
We foster an inclusive and safe workplace where our diverse people and members are all welcome.
INTEGRITY
We maintain the confidence and trust of our stakeholders through our honesty, transparency, and authenticity.
Dr Christian Wriedt Elected Fellow
Ms Yvonne Warner Independent Director
A/Prof Dion Forstner Elected Fellow
Prof John Slavotinek President
Dr Kate O’Connor Elected Fellow
Dr Rajiv Rattan Dean, Faculty of Clinical Radiology
Ms Maryjane Crabtree Board Chair
Prof Catherine Jones Elected Fellow
Dr Tuan Ha Dean, Faculty of Radiation Oncology
PRESIDENT’S MESSAGE
It is timely, in the 90th year of the College, that we reflect on our many recent successes in radiation oncology and clinical radiology. Our two disciplines are both indispensable and at the forefront of medicine, in no small part due to continued advances in technology and our adaptable forward-thinking membership. Aside from past success, it is also appropriate to consider current challenges and opportunities and, importantly, how best to manage our path into the future.
During the past year, RANZCR’s 2025-2040 Strategic Plan was introduced and implemented. The emphasis in the first three years is appropriately upon core College activities. These three activities are member experience and services, excellence in training and lifelong education, and continued advocacy as the voice of the sector. The strategic plan will be reviewed and adapted to evolving circumstances on a three yearly basis as we move into the future.
The pace of regulatory reform in Australia and New Zealand remains frenetic with multiple new consultations continuing to arise. In Australia, the expedited pathway
to registration of international medical graduates continues to pose challenges, as does the expedited pathway for registration in a provisional vocational scope of practice in New Zealand. Both pathways provide no place for College assessment or advice and some proposals envisage a purely paper-based process.
These and other external initiatives will continue to test our strategy, resilience and advocacy in order to protect the interests of our patients and members. Fortunately, relative to its peers, the College remains financially healthy and is therefore able to respond to challenges that may require additional resources.
The National Lung Cancer Screening Program was announced by the Federal Government in 2023 and commenced on 1 July this year. Obviously, implementation of such a program requires significant input from radiologists who are key to the process. Cancer Australia was funded to implement this program and has necessarily engaged the College and its members to provide key resources. Setting aside significant concerns regarding the quantum of funding provided by the government for individual screening CT scans, the last year has seen our members collaborate in impressive fashion to deliver multiple projects under tight timelines. As a result, a structured reporting framework, image acquisition, nodule management and other protocols, workshops and educational modules have been provided to support introduction of the program. This outstanding outcome exemplifies what can be achieved when the College, its members, staff and special interest
groups work together. My thanks go to those dedicated members and College staff involved.
On access, over the past year there has been an exponential increase in the number of Medical Treatment Overseas Program (MTOP) applications for overseas proton treatment. We have been collaborating with the Department of Health to streamline the process of MTOP applications so that patients can access muchneeded overseas proton therapy in a timely manner. Comparative planning for proton treatment has also been given an MBS number and this compensates centres for efforts providing and interpreting comparative proton/photon plans.
I would also like to celebrate the success of radiation oncology in implementation of the new MBS funding schedule for radiation therapy, effective from July 2024, which is a result of RANZCR’s decades-long advocacy. This marks a significant milestone in advancing equitable access to essential healthcare services.
On governance, the Board has benefitted from the experience and skills of Maryjane Crabtree, an experienced Chair who has provided sound advice as well as considerable governance expertise while chairing Board meetings.
In the coming year, in keeping with the strategic plan, our priorities will include education and professional development; advocacy for our professions; and improving member experience and services. I look forward to another productive and collaborative 12 months and convey my thanks to all College members and staff for their hard work, contributions and ongoing commitment.
Prof John Slavotinek
TREASURER’S REPORT
The Financial Statements for the year ending 30 June 2025 along with the Auditor’s Report are presented in this document. A detailed version of the Financial Statements will be available on the College website
www.ranzcr.com
Financial Year 2025 (FY 2025) marked another successful period, further solidifying the College’s financial position. The College generated an operating surplus of $6.3 million, exceeding budgetary expectations and an increase on FY 2024. This strong surplus position was driven by increased revenue across key areas, the benefit of a favourable macroeconomic climate on interest incomes, and effective expense management resulting in cost savings.
Operational revenues totaled $29.9 million, an increase on FY 2024 revenues of $27.2 million. Membership subscription revenues are the primary revenue resource, contributing $13.8 million (46% of total revenue). This revenue also grew in FY 2025 by $0.7 million. Other key revenues include fees from International Medical Graduates, which grew by $0.5 million in FY 2025, to $2.0 million. Revenues from external interest and investment amounted to $3.0 million, growing by $0.7 million comparative to FY 2024.
Total expenses were $26.2 million, an increase on FY 2024 expenses of $23.1 million. Expenses were below budget across most operating areas.
The College maintains a robust
balance sheet position. Total current assets stand at $33.2 million, offset by total current liabilities of $25.4 million. This results in a healthy liquidity ratio of 1.3 times. Cash and external investments collectively total $51.6 million.
In alignment with the 20252040 Strategic Plan, the College is developing a comprehensive framework to prioritise investment allocation for the medium to long term.
RANZCR medical initiatives supporting College performance through FY 2025 are highlighted below.
Operationalisation of 2025-2040 Strategy
In FY 2025, the College organised a series of meetings and workshops with individual strategic priority leads and members of the Executive Leadership Team. There were 16 strategic projects identified and prioritised for Horizon 1 that focus on three strategic priorities:
• Member fulfilment;
• Excellence in training and lifelong development; and
• Voice of the sector.
After identifying the prioritised strategic projects, the College completed a business restructuring to align with the strategic plan.
In preparing the FY 2026 budget, funds and resources have been allocated to the prioritised strategic projects to ensure their successful execution.
Dr Christian Wriedt
President’s Message
Policy, Advocacy and Standards
In FY 2025, the College achieved significant milestones, including Cancer Australia-funded facilitated webinars and a workshop for stillbirth investigation services, and supported training development for occupational dust lung disease and silicosis.
The CPD home was promoted, attracting new Associate members. Additionally, IR and INR programs were approved by the Board and set to launch in 2026.
The College actively represented its position to governments, regulatory bodies and other stakeholders at both federal and state levels across Australia and New Zealand. This program focuses on advocating to advance excellence in diagnostic, interventional and cancer care medicine, to optimise health outcomes for our patients and society.
Program Funding
In FY 2025, the College successfully filled all 52 Specialty Training Program (STP) positions, 6 Integrated Rural Training Pathway (IRTP) positions, and 2.5 Tasmanian Project (TAS) positions. In addition, government approval was granted for two additional positions under the Rural and Remote Training Pathway (RRTP), increasing the total funded positions to seven. All seven RRTP positions were successfully filled. The College remains committed to advocating for the continuation of funding and the further expansion of the RRTP beyond 2025.
Indigenous Trainee Support
In FY 2025, the College has successfully secured additional funding under the Flexible Approach to Training in Expanded Settings (FATES) initiative. This funding will provide 12 scholarships to support existing
and prospective Clinical Supervisors, Directors of Training, and College committee members in developing their expertise in medical education. Focus will be given to regional and rural Clinical Supervisors, First Nations Fellows, members of RANZCR education and training committees, and newly graduated student members.
Accreditation
The Clinical Radiology and Radiation Oncology Training Accreditation Standards were recently approved and will be progressively implemented over the next year, with ample transition time provided to the sites.
International Medical Graduates
In FY 2025, the College launched a defined scope pathway for assessment of international medical graduates. The defined scope outcome is restricted to Interventional Radiology, Interventional Neuroradiology and Paediatric Radiology. An international medical graduate assessed under a defined scope pathway will not be eligible for Fellowship of the College. An international medical graduate who wishes to attain a Fellowship will need to complete the Phase 2 exams and Phase 2 assessments.
Memberships and Events
The American College of Radiology (ACR) training and education sessions were hosted in August with 157 attendees joining the sessions. This was followed by the Perth ASM in October which had 1,312 attendees, over 100 seminar sessions and 97 industry partner representations. The ASM offered a range of educational opportunities for members to attain their CPD hours.
The Stripe membership payment gateway was launched
“FY 2026 forecasts sustained resilience in the College's financial position.”
in FY 2024 to enhance the convenience of making online payments. Further developments for the payment gateway are ongoing.
Member volunteers maintain a high level of engagement with the College, with 1,597 members generously contributing their time and efforts in a variety of areas.
Financial Outlook FY 2026
FY 2026 forecasts sustained resilience in the College’s financial position, with an anticipated surplus of $1 million. This figure is lower than FY 2025 for several reasons. Firstly, this is the first budgeting year inclusive of investments and resources allocated to strategic projects. Secondly, the College will continue to develop ongoing programs relating to hospital accreditation, trainee development, and member support. Thirdly, market volatility, softening macro-economic factors and geopolitical uncertainty are expected to impact external investments and interest income. Additionally, continued price increases for resources and purchases are anticipated. The College is also marginally increasing fees by 2.5% aligning with the projected CPI.
As part of the investment framework, the College will be consistently allocating funding to support operational resilience, research, education and the 2025-2040 Strategy.
The College’s balance sheet, cash position and investment portfolio values are also expected to remain consistently healthy through FY 2026.
CEO’S MESSAGE
This is RANZCR’s 90th year and our 75th year of delivering our Annual Scientific Meeting (ASM). I am sure that the College founders would be amazed and quietly proud of where their groundbreaking steps have led us to today. Very few organisations make it to their 90th anniversary and fewer still reach that milestone with our impressive record of growth and achievement for our members, and for improved patient outcomes across Australia, Aotearoa New Zealand, Singapore and beyond.
RANZCR today is a wellrespected, innovative, and fiscally sustainable college. Our training programs, our trainees and our Fellows are recognised as being among the best in the world. Our large cohort of member volunteers generously offer their time and expertise to advance the College and the health sector. We have an authorative and sought-after voice with government, the bureaucracy, the regulators, and the broader domestic and international health sectors.
A key to RANZCR’s continued
success is its ability to anticipate changes that are likely to impact its ecosystem and to evolve to meet those changes. The pace of sector change is accelerating and this presents new challenges and opportunities for the College.
At last year’s RANZCR AGM, the membership endorsed the introduction of an independent Chair to the RANZCR Board to work alongside the RANZCR President in the delivery of Board governance and business objectives; and the establishment of a Nominations Committee to assess applicants for future Board positions. The RANZCR AGM also saw the unveiling of the 2025-2040 RANZCR Strategic Plan.
The RANZCR Board recognised that successfully integrating the new Chair role into our governance framework would require a highly experienced and well-credentialled professional Chairperson. The calibre of person we were seeking would likely be in demand from larger and more complex companies, and unable to commit to RANZCR in the longer term, so RANZCR positioned the inaugural Chair role as a 12-month interim engagement, with a permanent Chair to be recruited at the conclusion of the 12-month interim engagement.
The recruitment process resulted in the Board appointing Maryjane Crabtree as RANZCR’s inaugural Board Chair, on a 12-month interim basis. Maryjane is a lawyer by profession and practised as a solicitor in Melbourne for 35 years, mainly at a leading national firm Allens, before retiring in 2016. She is also a highly experienced Director with a wealth of governance experience, who has served on a
range of boards and committees and has consulted to organisations on governance and integrity.
Maryjane has made an immediate impact on Board dynamics and governance and RANZCR is now well positioned to appoint a permanent Board Chair for 2026.
The past Financial Year saw the approval and introduction of RANZCR’s new 2025-2040 Strategic Plan. This ambitious 15-year plan, divided into three time horizons and with regular review points that allow for the plan to evolve in response to changing circumstances, envisages the potential for a significantly different College in 2040. The first three-year horizon of the plan focuses on strengthening our core; member fulfilment; excellence in training and lifelong education; and being the voice of the sector.
Early in 2025, RANZCR undertook a realignment of its business structure to build three delivery business units aligned to the Horizon 1 priority areas. This change saw several reporting line changes for our people, some role changes, and a reduction in the number of our General Managers. It also saw the appointment of key staff to lead each priority area and the creation of a new position to lead and shape the implementation of the plan, working across the College to drive the implementation of the plan.
This realignment recognised the need to invest in areas that better supported our members, and staff were employed to strengthen this support.
Several large projects are now underway and a regular management and board reporting framework is in place to ensure that the plan is delivered.
Underlying this activity is
Duane Findley, CEO
an ongoing cultural realignment that emphasises the centrality of the member experience. Anecdotal feedback suggests that many of our members have noticed this positive change within the College.
RANZCR’s long and successful history, its central position today, and its potential over the next 15 years, is an outcome of the hard work and commitment of the RANZCR Board, our Faculty Councils, our incredible volunteer members, our dedicated staff, and our partners and supporters; past and present. Working together, we make RANZCR greater than the sum of our parts and the result is your College. Thank you for your contribution.
The next year is certain to see more proposed regulatory and ecosystem change, more uncertainty and a greater burden placed on RANZCR to remain ahead of these changes. Implementing our strategic plan while managing and adapting to the waves of change will be challenging, but our College is well placed to succeed in this environment.
THE COLLEGE ONLINE
COLLEGE SOCIAL MEDIA
4,706 X Followers
RANZCR WEBSITE
OTHER MEDIA AND ADVOCACY
5,886
AU
RESEARCH GRANTS AWARDED
$99,625
AU
(CTCA) 5,500
CREDENTIALING
CT COLONOGRAPHY (CTC)
registered specialists (radiologists only) 208 registered specialists (includes radiologists and cardiologists)
INTERVENTIONAL NEURORADIOLOGY (INR)
recognised specialists (includes radiologists, neurologists and neurosurgeons)
934 registered specialists
Level A CTCA: 619
Level B CTCA: 315 (includes radiologists, cardiologists and nuclear medicine specialists)
KEY ACHIEVEMENTS
Annual Scientific Meeting, Perth
Themed ‘A Gathering Under the Stars’, the Perth ASM united 1,312 attendees through a diverse threeday program. With over $848,000 in sponsorship and exhibition revenue, the meeting featured 321 abstracts and 250+ speakers across 100 sessions. Highlights included expanded interventional streams and dedicated radiation oncology sessions. Social and educational events such as Lunch & Learns and the Women in Leadership Breakfast delivered additional member value.
Artificial Intelligence in Healthcare
Continuing RANZCR’s leadership in the AI space, two position papers were published, providing guidance to members and the wider community on Autonomous AI and Generative AI.
Changes to Medicare Funding for Rectal MRI
RANZCR consulted with the Department of Health and Aged Care (DoHAC) to put forward an amendment to the Medical Services Advisory Committee (MSAC) to expand rectal MRI item 63476, where a once in a lifetime rebate restriction applied. In November 2024, an amendment was announced, giving full access to MRI scans of the pelvis for rectal cancer restaging and patients on a ‘watch and wait’ surveillance program.
CPD Program
RANZCR has continued to make refinements to its CPD program and the CPD ePortfolio based on member feedback ensuring alignment to the AMC, MBA and MCNZ requirements. RANZCR achieved CPD compliance of 95% for the 2024 CPD year.
CRM Optimisation Project
The CRM Optimisation Project, now 40% complete, marks a significant shift in member engagement capabilities. Focused on real-time marketing, improved data governance and operational efficiency, the upgrade enables personalised member communication and workflow automation. Key wins include enhanced email functionality through Microsoft Dynamics, reduced manual workload, and deeper data insights. Staff are equipped with tailored training and user guides. The project ensures that member interactions are timely, relevant and driving longterm engagement and strategic fulfilment.
Health Workforce NZ
We continue to work closely with Health Workforce (NZ) and we provided robust data to develop a current picture of clinical radiology and radiation oncology in New Zealand. Our data can be used to support sites requesting funding and to help understand the need to increase and retain our workforce.
IR & INR
RANZCR successfully completed the first stage of piloting the new IR/INR Training Program, preparing the way for full roll-out for trainees who wish to pursue advance training in these areas.
Medical Treatment Overseas Program (MTOP)
The Faculty of Radiation Oncology provided extensive advice to Department of Health, Disability and Aging (DHDA) via the Medical Treatment Overseas Program (MTOP), enabling timely access to proton therapy overseas for patients who need access to this treatment.
MRI Licensing Deregulation
Following persistent campaigning and collaborative discussions with the Department of Health and Aged Care (DoHAC), the government announced the complete removal of MRI licences by specific dates: from July 2025, practices with existing licences will receive a comprehensive 'practice-based' licence, and by July 2027, all ineligible MRI machines in comprehensive diagnostic imaging practices will be upgraded for full Medicarefunded MRI services access.
National Lung Cancer Screening Program (NLCSP)
The NLCSP launched on 1 July 2025, marking the first new screening program in Australia in nearly 20 years, with the potential to save hundreds of lives each year. The College and
the Australian & New Zealand Society of Thoracic Radiology (ANZSTR) worked with Cancer Australia and the Department of Health, Disability and Ageing to ensure that the radiology sector was prepared to participate in the Program. RANZCR/ANZSTR produced the Structured Clinical Radiology Report and an educational package to train and upskill radiologists interested in the Program. Webinars, workshops and an online set of education modules were created and presented by members of ANZSTR NLCSP Steering Committee and the lead clinical education writer. The education materials are now available on the College’s NLCSP webpage.
Publication of the Facilities Survey Report
The Facilities Survey Report: Insight and Trends from 20102020, New Zealand is a milestone publication bringing together a decade's worth of data from the Facilities Survey and offers a thorough analysis of the current state of radiation oncology in NZ.
Radiation Oncology MBS
RANZCR developed educational materials and advised the Department of Health and Aged Care on the clinical aspects of interpreting the new Medicare Benefits Schedule (MBS) for radiation oncology.
Removal of Provider Restriction
RANZCR has advocated that Cardiac MRI for myocarditis does
not require provider restrictions. The service is now amended to be provided by a specialist in diagnostic radiology or a CCMRI recognised provider (effective 1 January 2025).
Targeting Cancer Joint Campaign with ASMIRT
In partnership with ASMIRT, RANZCR delivered a co-branded social campaign that amplified awareness of radiation therapy across Australia and New Zealand. Through informative blogs, videos, and graphics, the campaign promoted patient empowerment, multidisciplinary care, and GP education. Shared across LinkedIn, Facebook, and X, the posts achieved strong engagement. The initiative was well executed for collaborative impact, generating meaningful conversations in cancer care and positioning RANZCR as a leading voice for accessible radiotherapy treatment.
Training
The College successfully recruited roles of First Nations Medical Educationalist and First Nations Trainee Liaison Officer, funded by Flexible Approach to Training in Expanded Settings (FATES), to provide individual trainee support, education and training to key clinicians to foster a culturally safe and inclusive training environment. In addition, these roles have engaged with First Nations stakeholders and provided guidance across wider college activities.
In 2025, the College secured
funding for two additional posts under Regional and Rural Training Pathway (RRTP) pilot program, dedicated to First Nations trainees who commenced their metropolitan rotations in NSW and QLD respectively this year.
Under Specialist Training Placements and Support (STPS), the College achieved 98% fill rate, filling 51 posts, with 34 in clinical radiology and 17 in radiation oncology. More than 70% of these filled posts were regional and rural, located in Modified Monash Model (MMM) 2019 category MMM2 – MMM4.
In 2025, the College achieved 100% fill rate under Integrated Rural Training Pipeline (IRTP) and Training More Specialist Doctors in Tasmania (TAS Project).
Implementation of Collegewide Selection into Training Policy, providing candidates with a more transparent, fair and equitable process to gaining a specialty training position. Additionally, the process allowed a more efficient onboarding process for trainees.
Introduction of the Defined Scope Pathway for IMGs wanting to work in IR/INR or Paediatrics.
Development a series of online modules for new DoTs enabling new DoTs to access relevant information in a more timely and efficient manner.
EXAMINATION RESULTS
Assessment Name: 2024 Phase 2 OSCER Sitting 2
Phase 1 Series 2 2024 Anatomy
(80%)
Phase 1 Series 1 2025
Assessment Name: 2025 Phase 2 OSCER Sitting 1
Phase 2 Series 2 2024
Pass Rate = 65.2%
Phase 2 Series 1 2025
Pass Rate = 78.9%
Overall across the 2 series 30 candidates met all Phase 2 Examination requirements and will be eligible for Fellowship subject to completion of all other requirements of the training program or IMG assessment requirements.
AUDITOR’S REPORT
FINANCIALS
The Royal Australian and New Zealand College of Radiologists Statement of profit or loss and other comprehensive income For the year ended 30 June 2025
The Royal Australian and New Zealand College of Radiologists Statement of financial position As at 30 June 2025
FINANCIALS
The Royal Australian and New Zealand College of Radiologists Statement of changes in equity For the year ended 30 June 2025
The above statement of financial position should be read in conjunction with the accompanying notes, available via www.ranzcr.com
The Royal Australian and New Zealand College of Radiologists Statement of cash flows
For the year ended 30 June 2025
The above statement of financial position should be read in conjunction with the accompanying notes, available via www.ranzcr.com
NEW FELLOWS
ACT
Abigail Ng
Chia Ven Low
Grant Buchanan
Marie Mansfield
NSW
Akshay Kohli
Alexander Kirwan
Amer Mitchelle
Aniket Adhikari
Angelis Belessis
Andy Ho
Arridh Shashank
Ashutosh Dixit
Blake Milton
Cameron Grant
Charlotte Yin
Cheng Hong Yeo
Daniel Mills
David Cottle
Dina Hikmat
Douglas Dunn
Eoin O'Malley
Emma Grierson
Eric Fong
Fiona Lau
Frank Dorrian
George Cosman
George Sidhom
Isidoro Ruisi
Jake Ball
Joan-Albert Prat Matifoll
Joshua Yap
Julie Ahn
Kevin Sheng
Kit Ho Lee
Mohamed Zehairy
Peter Zarzour
Reuben Tang
Sameer Dave
Sean Hassan
Sonal Sachdev
Soo-Min Cho
Sunday Owoeye
Theresa Cook
Tracy Lim
Wendy Huang
Ya Ruth Huo
Zoe Clayton-Smith
NZ
Angelo Di Bartolo
Ashley Ellis
Ashutosh Dixit
Bo Mi Kim
Darran Rouse
Gareth Le Grice
Jonathan Bong
Jin Xu
Matthew Jeans
Seoung Yeun Han
Shalini Parinpanayagam
Syed Waleed
Ahmad Bukhari
Thomas Doolin
Zaineb Ukra
Overseas
Bruce McIvor
Chia Ching Lee
Chieh-Cheng Huang
Elias Sachawars
Lisa Luo-Lan Ling
Noor Ridha
Tubo Shi
QLD
Alexis Ford
Andrew Taylor
Ashley Ellis
Christopher Rothe
Crishan Haran
David Alves
De Araujo Junior
Dionee Liefman
George Hinton
Himanshu Thalagala
Jack Langford
Jeffrey Cheng
Junise Moideen
Kimberley Budgen
Lachlan Inch
Liam Pugh
Maciej Debowski
Mark Bekhit
Michelle Peterson
Mohammed Shah
Nasir Babakhan Kondori
Nicholas D'Arcy
Peter Houston
Phoebe Allison
Pui Kit Yip
Rishabh Verma
Roger Baker
Roy Machasio
Sameera Allu
Stephanie Aroney
Thomas Pearson
Vijay Mistry
SA
Aaron Jin
Aaron Rayan
Amy Gibney
Antonia Knight
Brian Barker
Callum Smith
Chantelle Ip
Danielle Coupland
George Hinton
Jae-Gon Yoo
Luzinda Lo
Maria Afzal
Nikola Tomanovic
Yamin Li
TAS
Jonathon Saner
VIC
Adrian Tinney
Alexander Berry
Alexandre Massaki
Amandeep Sandhu
Andrew Feehan
Anthony Lamanna
Arnulf Mayer
Ashwathy Mathew
Bridget Copson
Daniel Chin
Deepa Devi
Georgina Aberdein
Grant Foster
Haur Wey Tan
Harrison McKenna
Jae-Kwan Jun
Jason Au
Jamie Cooke
Kary Suen
Matthew Warrender-Sparkes
Michael Wang
Monica Wong
Neil Wallace
Prudence Chamberlain
Rachel Gordon
Reuben Sum
Rohith Gollapinni
Salam Findakly
Sandra Lin
Stephanie Dawson
Sujeewa Gardiarachchi
Tahleesa Cuda
Upuli Pahalawatta
Valentine Ho
Viyalapalle
Amarasinghe
Xien Lei Liversidge
Yousr Al-Sheibani
WA
Andrew MacDonald
Caoilfhionn Ni Leidhin
Chi-Wei Robin Yang
Daniel Ward
David Becker
Dilini Jayasinghe Arachchi
Joel Earley
Jing Liu
Kieran Kusel
Lyndsey Edwards
Nicholas Willmore
Samuel Wellman
Sarah Osiemo
Sriram Vaidyanathan
Stephen Kennedy
Subhani
Wickramasinghe
Wadiya Bandara
COLLEGE GRANTS, AWARDS AND PRIZES
College Honours
Gold Medal
Dr Keen Hun Tai
Roentgen Medal
A/Prof Nick Ferris
Honorary Fellowship
Prof Roland Bammer, Dr Geraldine McGinty
Clinical Radiology Educational Service Award
Dr Shaun Gallagher
Life Membership
Dr Wayne Lemish, Dr Alan Klevansky, Dr John Gunn
Denise Lonergan Educational Service Award
Dr Tanya Holt
RANZCR Annual Indigenous Scholarship
Dr Jessica Del Bianco
Research Awards and Grants
Faculty of Radiation
Oncology Bourne and Langlands Prize
Dr Ravi Marwah
Clinical Radiology Early Career Researchers Prize
Dr Ya Ruth Huo
Radiation Oncology Research Grants
Dr Anna Lawless, Dr Ryan McMahon, Dr Eric Wegener, Dr Tao Xing, Dr Carminia Lapuz, Dr Joseph Chang
Clinical Radiology Research Grants
Dr Dee Zhen Lim, Dr Aaron Wong, Dr Samuel White, Dr Seamus O'Flaherty, Dr Samuel Davis, Dr. Daren Gibson
Withers and Peters Grant Radiation Oncology
Dr Anna Lawless
Indigenous Health Prize
Dr Arockia Doss
Faculty of Radiation Oncology Quality Improvement Project Prize
Dr Shanuka Samaranayake
International Development Fund
A/Prof Eng-Siew Koh, Prof Dinesh Varma
ASM Prize Recipients
Wiley Best Exhibit Award - Clinical Radiology
Dr Peter Robins
Branch of Origin Prize
Dr Richard Kelly
Chris Atkinson Award
Dr Ziad Thotathil
Elekta Award
Dr Vicky Chin FROGG Prize
A/Prof Wee Loon Ong
Varian Prize
Dr Shanuka Samaranayake
NZ Radiology Education Trust Radiation Oncology Award
Dr Ziad Thotathil
Best IR Presentation
Dr Krishna Pranathi Settipalli
Educational Fellowships
Thomas Baker Fellowship
Dr Cristian Udovicich
Bill Hare Fellowship
A/Prof Craig Hacking
Windeyer Fellowship
Dr Tracy Lim
Exam Prizes
CE Eddy Prize Radiation Oncology
Dr Edward Chmiel
CE Eddy Prize Clinical Radiology
Dr Alexander Chua
HR Sear Prize Clinical Radiology
Dr Douglas Dunn
MGF Donnan Prize
Dr Arpit Talwar
Uhr Clarke Bursary Award
Dr Thomas Pearson
Branch Awards
NZRET Poster Prize (NZ)
Dr Mina Ibrahim
NZRET Radiation Oncology Research Award (NZ)
Dr Ziad Thotathil
Obex Radiology Registrar Research Award
Dr Richard Kelly
Pikimairawea Award
Dr Carol Johnson and Prof Anthony Butler
SPONSORS
We acknowledge the valuable support provided by the following sponsors throughout the year:
4DMedical
Abbott Medical
Advahealth Solutions Pty Ltd
AGFA HealthCare Australia
Aidoc
Airs Medical
Alphatec Spine
alphaXRT
Annalise.Ai
AstraZeneca
Auckland Radiology Group
Australian Digital Health Agency
Australian Radiation Protection and Nuclear Safety Agency
Bay Radiology
Bayer
BD
Becton Dickinson Pty Ltd
Blackford
Boehringer Ingelheim
BOQ Specialist
Boston Scientific
Brainlab Australia Pty. Ltd
Canon Medical
Capitol Health
Carlisle Health
CARPL.ai, Inc.
Cass
Comrad Medical Systems
CWH Medical
DPI
Eagleheart
EIZO APAC
Elekta Pty Ltd
EPIC-X Pty Ltd
Everlight Radiology
EverX Pty Ltd
Fujifilm
Gamma Gurus Pty Ltd
GCG Healthcare
GE HealthCare
GenesisCare
Gleamer
Guerbet
Health Education and Training Institute
Healthinc
Hospital Staff Solutions
HosPortal
ICON
Imaging Solutions Pty Ltd
I-MED Radiology Network
Inari Medical Pty Ltd
Incentive Project Management and Consulting
Integral Diagnostics
Intelerad Medical Systems
Incorporated
Interfuse Technologies Pty Ltd
Ipsen Pty Ltd
I-Telerad
Kestral
LG Electronics Australia
Lumus Imaging
Lungscreen
MDA National
MedCurrent Corporation
Merit Medical
Microsoft
Mundipharma
OncoBeta Therapeutics
Ozdoc Solutions Partnership Pty Ltd
Pacific Radiology Group
Paragon
Pearce
Penumbra Inc.
Perthradclinic Ltd
Philips
Professional Radiology Outcomes
Qscan Services Pty Ltd
RaySearch Laboratories
Regional Health Care Group
RHCNZ Medical Imaging Group
Sectra Pty Ltd
See-Mode Technologies
Siemens Healthineers
Sirtex
Soliton IT
Solventum
Sonic Healthcare Australia
Radiology
Strategic Care
Stryker
The Ohio State University
Varian
Vengage
Voyager Imaging
Western Radiology
DECEASED MEMBERS
It is with regret that we record the deaths of the following members during the year under review:
Anthony David Pryde, Bruce Collings, Charles Norman Matthews, Kenneth Edwin Goard, Michael Gerard Purcell, Peter John Austin Carr, Ramon Wayne Lun, Robert George Bourne, Sean Michael Brennan, Valerie Mayne, Wayne Wai-kung Wong, William Woods
Level 9, 51 Druitt Street, Sydney NSW 2000, Australia. ABN 37 000 029 863 T +61 2 9268 9777 E ranzcr@ranzcr.edu.au Wellington, New Zealand
T +64 4 472 6470 E nzbranch@ranzcr.org.nz